
Epiwil D 750mg Tablet ER
Marketer
Pifer Pharmaceuticals Pvt Ltd
Salt Composition
Divalproex (750mg)
Overview Epiwil D 750mg Tablet ER
Epileptic seizures and migraine prophylaxis are addressed by the extended-release formulation of Valproex 750mg tablets. This medication controls seizures and may also be prescribed for bipolar disorder management, sometimes in conjunction with other treatments. Dosage and frequency are determined individually by your physician to optimize symptom control. Administering this medication with or without food is acceptable, but maintaining consistent daily timing maximizes effectiveness. Therapeutic effects typically manifest within a couple of weeks. Consistent use, as directed, is crucial; discontinuation or missed doses risk seizure recurrence and condition exacerbation. Abrupt cessation is contraindicated. Common, generally mild, side effects include headache, visual blurring, nausea, vomiting, dizziness, fatigue, instability, easy bruising, and hypothermia. Persistent or bothersome side effects warrant medical consultation, while skin rashes demand immediate attention. Prolonged use may reduce bone density (osteoporosis), increasing fracture risk. Suicidal ideation and behavior are rare but serious potential side effects; report any mood changes to your physician immediately. Prior to initiating treatment, inform your physician about any history of cardiac issues, hepatic or renal impairment, urinary difficulties, depression, or suicidal thoughts. Drug interactions are possible; disclose all medications currently in use to ensure safety. Consult your doctor before altering medication use during pregnancy. Alcohol consumption should be minimized due to increased side effect and seizure risk. Regular blood tests may be necessary for dose monitoring, both initially and throughout treatment.
Uses of Epiwil D 750mg Tablet ER
Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prevention
Major Benefits of Epiwil D 750mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epiwil D 750mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Epiwil D 750mg Tablet ER:
- Decreased body temperature
- Dizziness
- Sleepiness
- Tremors
- Paresthesia (tingling or pricking sensation)
- Anemia (low number of red blood cells)
- Decreased sodium level in blood
- Liver injury
- Gastrointestinal disturbance
- Hypersensitivity
- Deafness
- Urinary incontinence
- Increase in body weight
- Pain during periods
How to use Epiwil D 750mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epiwil D 750mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
How Epiwil D 750mg Tablet ER works:
Epileptic seizures are managed by the extended-release anticonvulsant, Epiwil D 750mg Tablet ER. This medication reduces the hyperactivity of neurons in the brain, thus controlling convulsions.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Epiwil D 750mg extended-release tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Epiwil D 750mg tablets pose a confirmed risk to a developing fetus and should not be used during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Epiwil D 750mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Epiwil D 750mg tablets can induce adverse reactions that may impair driving capabilities.
KidneySAFE IF PRESCRIBED
Extended-release Epiwil D 750mg tablets are considered safe for use in individuals with impaired renal function. No alteration of the Epiwil D 750mg extended-release tablet dosage is necessary.
LiverUNSAFE
Extended-release Epiwil D 750mg tablets pose a likely risk for individuals with hepatic impairment and should be omitted. Physician consultation is advised.
What if you forget to take Epiwil D 750mg Tablet ER :
Should you forget a dose of Epiwil D 750mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Epiwil D 750mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Derivatives of Aliphatic Carboxylic Acids |
| Developing Habits | No. |
| Type of Treatment | Central Nervous System (CNS) Neurology |
| Active Class | Anticonvulsant sodium channel blockers |
